Lithium is NOT Contraindicated in Hypothyroidism
Lithium is not contraindicated when a patient has hypothyroidism—this is a common misconception. The FDA drug label does not list hypothyroidism as a contraindication 1, and clinical practice guidelines explicitly state that "previously existing underlying thyroid disorders do not necessarily constitute a contraindication to lithium treatment" 1.
What the Evidence Actually Shows
Lithium Can Be Used Safely in Hypothyroid Patients
The key principle from both FDA labeling and clinical guidelines is that hypothyroidism requires monitoring and management during lithium therapy, not avoidance of lithium 1. The FDA label specifically states: "where hypothyroidism exists, careful monitoring of thyroid function during lithium stabilization and maintenance allows for correction of changing thyroid parameters, if any" 1.
If hypothyroidism develops or worsens during lithium treatment, supplemental thyroid hormone replacement should be added 1. This approach allows patients to continue benefiting from lithium's mood-stabilizing effects while managing thyroid dysfunction.
Why Lithium Affects the Thyroid
Lithium interferes with thyroid function through multiple mechanisms 2:
- Inhibits thyroid hormone synthesis and release
- Decreases peripheral conversion of T4 to T3
- Concentrates in thyroid tissue and inhibits iodine uptake
- Can trigger or worsen autoimmune thyroiditis in susceptible individuals
The risk is dose-dependent, with higher lithium levels causing greater TSH elevation 3. Clinical hypothyroidism occurs in approximately 10.4% of lithium-treated patients, with women at substantially higher risk (14% vs 4.5% in men), particularly those aged 40-59 years 4.
Clinical Management Algorithm
Before Starting Lithium:
- Obtain baseline TSH, free T4, and consider anti-thyroid peroxidase antibodies [@1,2,3,4,5,6,7@]
- Pre-existing hypothyroidism should be optimally treated but does not preclude lithium use
During Lithium Therapy:
- Monitor thyroid function periodically (at minimum annually) [@1,2,3,4,5,6,7@]
- More frequent monitoring for high-risk patients: middle-aged women, family history of thyroid disease, positive thyroid antibodies 5
- If hypothyroidism develops: initiate levothyroxine replacement while continuing lithium 1
Important Caveat About Severe Hypothyroidism:
One critical exception exists: profound hypothyroidism can precipitate lithium toxicity 6. A case report documented severe lithium toxicity requiring ICU admission and hemodialysis in a patient who stopped thyroid hormone for 3 weeks prior to radioactive iodine treatment 6. The mechanism is renal dysfunction associated with severe hypothyroidism, which impairs lithium clearance and causes toxic accumulation.
Therefore, patients with severe, untreated hypothyroidism should have their thyroid function optimized before initiating lithium or should have lithium doses adjusted downward with close monitoring.
The Reversibility Question
Importantly, lithium-induced hypothyroidism appears reversible in many patients. When lithium is discontinued, approximately 41% of patients can successfully stop thyroid replacement therapy without recurrence 7. This suggests the thyroid dysfunction is often a direct pharmacologic effect rather than permanent damage.
Bottom Line for Clinical Practice
Do not withhold lithium from patients with controlled hypothyroidism. Instead, ensure thyroid hormone replacement is optimized, monitor thyroid function regularly during lithium therapy, and adjust thyroid replacement as needed. The only scenario requiring extreme caution is severe, untreated hypothyroidism due to risk of lithium toxicity from impaired renal clearance 6.